Try a new search

Format these results:

Searched for:

person:delacm03

in-biosketch:true

Total Results:

86


Eyelash trichomegaly secondary to panitumumab therapy

Morris, L G T; Hochster, H S; Delacure, M D
PMCID:3108868
PMID: 21655160
ISSN: 1198-0052
CID: 136473

Exploring factors in diagnostic delays of head and neck cancer at a public hospital. [Meeting Abstract]

Lai, D. W.; Buckley, S. A.; Schmidt, B. L.; Viet, C.; Muggia, F.; Belitskaya-Levy, I.; Cohen, R. F.; DeLacure, M. D.; Sanfilippo, N.; Myssiorek, D.; Hirsch, D.; Seetharamu, N.
ISI:000208880301688
ISSN: 0732-183x
CID: 3159162

Multiple cases of squamous cell carcinoma of the tongue and oral cavity in patients treated with long-term pegylated liposomal doxorubicin (PLD) for ovarian cancer. [Meeting Abstract]

Cannon, T. L.; Muggia, F.; Hirsch, D.; Andreopoulou, E. A.; Kerr, A. R.; DeLacure, M. D.
ISI:000208880301711
ISSN: 0732-183x
CID: 3159192

Lymph node central necrosis on computed tomography as predictor of extracapsular spread in metastatic head and neck squamous cell carcinoma: pilot study

Zoumalan, R A; Kleinberger, A J; Morris, L G T; Ranade, A; Yee, H; Delacure, M D; Myssiorek, D
Objective:This study aimed (1) to investigate the relationship between the presence of lymph node central necrosis, viewed on pre-operative computed tomography imaging, and the occurrence of histopathologically determined metastatic lymph node extracapsular spread and (2) to determine whether a larger scale study would be valuable.Materials and methods:Pre-operative computed tomography scans, surgical records and post-operative histopathological analysis results were reviewed for 19 consecutive neck dissections performed in 17 patients with head and neck squamous cell carcinoma.Results:A total of 20/26 (77 per cent) lymph nodes with central necrosis had extracapsular spread on histopathological analysis. Twenty of 21 (95 per cent) lymph nodes with extracapsular spread had central necrosis on pre-operative computed tomography. Thirty-four of 40 (85 per cent) lymph nodes without extracapsular spread had no evidence of central necrosis on computed tomography. Only three of 12 (25 per cent) patients with lymph node central necrosis identified on pre-operative computed tomography were found to have actual necrosis on final histopathological analysis.Conclusions:Lymph node central necrosis viewed on pre-operative computed tomography scans is a useful indicator of metastatic lymph node extracapsular spread, with a sensitivity of 95 per cent, a specificity of 85 per cent, a positive predictive value of 69 per cent and a negative predictive value of 98 per cent. Lymph node diameter is not a sensitive indicator of extracapsular spread
PMCID:3005594
PMID: 20573293
ISSN: 0022-2151
CID: 114815

Toxicity of head-and-neck radiation therapy in human immunodeficiency virus-positive patients

Sanfilippo, Nicholas J; Mitchell, James; Grew, David; DeLacure, Mark
PURPOSE: To examine the acute morbidity of high dose head and neck RT and CRT in patients with infected with HIV. METHODS AND MATERIALS: All HIV-positive patients who underwent radiation therapy for head and neck cancer in our department between 2004 and 2008 were reviewed. Treatment related data were examined. All treatments were delivered with megavoltage photon beams or electron beams. Patients were evaluated by an attending radiation oncologist for toxicity and response on a weekly basis during therapy and monthly after treatment in a multidisciplinary clinic. Acute toxicities were recorded using the Radiation Therapy and Oncology Group (RTOG) common toxicity criteria. Response to treatment was based on both physical exam as well as post-treatment imaging as indicated. RESULTS: Thirteen patients who underwent RT with a diagnosis of HIV were identified. Median age was 53 years and median follow-up was 22 months. Twelve had squamous cell carcinoma and one had lymphoproliferative parotiditis. Median radiation dose was 66.4 Gy and median duration of treatment was 51 days. The median number of scheduled radiotherapy days missed was zero (range 0 to 7). One patient (8%) developed Grade 4 confluent moist desquamation. Eight patients (61%) developed Grade 3 toxicity. CONCLUSION: Based on our results, HIV-positive individuals appear to tolerate treatment for head and neck cancer, with toxicity similar to that in HIV-negative individuals
PMID: 20097488
ISSN: 1879-355x
CID: 111341

Malignant melanoma metastatic to the larynx: treatment and functional outcome

Lanson, B G; Sanfilippo, N; Wang, B; Grew, D; Delacure, M D
The review considers management strategies for malignant melanoma metastatic to the larynx. This rare clinical entity lacks clear treatment recommendations because extirpative surgery can often result in severe functional debilitation in patients with limited life expectancy. Here, we report a case of melanoma metastatic to the larynx in a patient with a prior history of Hodgkin lymphoma. The patient was treated with partial laryngectomy and local radiation therapy. The rationale for treatment decisions and for surgical and radiotherapeutic techniques and the associated literature are discussed
PMCID:2913823
PMID: 20697525
ISSN: 1198-0052
CID: 133827

Head and neck radiotherapy compliance in an underserved patient population

Sethi, Rajni A; Stamell, Emily F; Price, Leah; DeLacure, Mark; Sanfilippo, Nicholas
OBJECTIVES/HYPOTHESIS: Compliance to intensive multiweek radiation therapy (RT) regimens in head and neck cancer (HNC) patients is challenging, particularly among medically underserved patients with fewer financial and social resources. Treatment prolongation reduces local control and overall survival rates, making adherence to treatment a key factor in optimal outcome. We evaluated factors affecting compliance in medically underserved patients who received RT for HNC in a large municipal hospital setting in New York City. STUDY DESIGN: Retrospective review. METHODS: Treatment records of patients treated between July 2004 and August 2008 were reviewed. Number of and reasons for missed treatments were identified. Several demographic, toxicity, and treatment variables were analyzed for impact on compliance. RESULTS: Eighty consecutive HNC patients who underwent RT with a 5- to 7-week regimen were identified. Thirty-two patients (40%) missed no treatments, 36 (45%) missed one to six treatments, six (8%) missed seven to 14 treatments, two (3%) missed more than 14 treatments, and four (5%) did not complete treatment. Reasons for missed treatments were hospitalization (31% of events) and toxicity (20%). Patients with percutaneous endoscopic gastrostomy tube were more likely to miss treatments (P = .01, chi(2) test). No other variable showed a significant association with missed treatments (chi(2) test). CONCLUSIONS: Intensive RT for HNC can be delivered with very good adherence within a medically underserved population. Eighty-five percent of patients completed treatment with 0 to 6 days of interruption. Efforts to further improve adherence in this population are ongoing
PMID: 20564718
ISSN: 1531-4995
CID: 110686

Pathology quiz case 1: ameloblastic carcinoma [Case Report]

Immerman, Sara B; Morris, Luc G T; DeLacure, Mark D; Wang, Beverly Y; Kurago, Zoya
PMCID:3014859
PMID: 20578291
ISSN: 0886-4470
CID: 156181

Validation of the histologic risk model in a new cohort of patients with head and neck squamous cell carcinoma

Brandwein-Gensler, Margaret; Smith, Richard V; Wang, Beverly; Penner, Carla; Theilken, Andrea; Broughel, Darcy; Schiff, Bradley; Owen, Randall P; Smith, Jonathan; Sarta, Cathy; Hebert, Tiffany; Nason, Rick; Ramer, Marie; DeLacure, Mark; Hirsch, David; Myssiorek, David; Heller, Keith; Prystowsky, Michael; Schlecht, Nicolas F; Negassa, Abdissa
BACKGROUND: Half of the patients with head and neck squamous cell carcinoma (HNSCC) can be expected to fail therapy, indicating that more aggressive treatment is warranted for this group. We have developed a novel risk model that can become a basis for developing new treatment paradigms. Here we report on the performance of our model in a new multicenter cohort. DESIGN: Eligible patients from 3 institutions (Montefiore Medical Center, University of Manitoba, and New York University Medical Center) were identified and pathology slides from their resection specimens were reviewed by Margaret Brandwein-Gensler; risk category was assigned as previously published. Kaplan-Meier analysis was performed for disease progression and survival. Cox proportional hazards regression was performed, adjusted for potential confounders. A teaching module was also developed; attending pathologists were asked to score coded slides after a lecture and multiheaded microscope teaching session. Agreement was assessed by calculating Cohen unweighted kappa coefficients. RESULT: The validation cohort consisted of 305 patients, from the above institutions, with 311 primary HNSCC of the oral cavity, oropharynx, and larynx. The median follow-up period for all patients was 27 months. Risk category predicts time to disease progression (P=0.0005), locoregional recurrence (P=0.013), and overall survival (P=0.0000) by Kaplan-Meier analysis. High-risk status is significantly associated with decreased time to disease progression, adjusted for clinical confounders (P=0.015, hazard ratio 2.32, 95% confidence interval 1.18-4.58) compared with collapsed intermediate and low-risk groups. We also demonstrate substantial interrater agreement (kappa=0.64), and very good rater agreement when compared with the standard (kappa=0.87). CONCLUSIONS: We demonstrate significant predictive performance of the risk model in a new cohort of patients with primary HNSCC, adjusted for confounders. Our training experience also supports the feasibility of adapting the risk model in clinical practice
PMID: 20414102
ISSN: 1532-0979
CID: 120802

Incidental trichinellosis of strap muscle identified after thyroglossal duct cyst excision

Kuhn, Maggie A; Zeitler, Daniel M; Wang, Beverly Y; DeLacure, Mark D
OBJECTIVES: (1) Present a unique case of a thyroglossal duct cyst (TGDC) excised for recurrent infections with Trichinella spiralis in adjacent strap muscle; (2) review the literature regarding the diagnosis and treatment of subclinical trichinellosis of the head and neck. STUDY DESIGN: Case report and literature review. METHODS: Case report and literature review. RESULTS: We present the case of a male immigrant who suffered from recurrent midline neck infections due to aTGDC. The patient underwent an uneventful Sistrunk procedure. Histological examination of the surgical specimen revealed a chronically infected TGDC as well as remnants of skeletal muscle adjacent to the cyst containing nematode larvae, positively identified as Trichinella spiralis. The patient was subsequently evaluated by an infectious disease specialist and required no further treatment for his parasitic infection. DISCUSSION: The presence of nematode infections in developed countries is rare today given improved hygiene practices and control of meat quality. We present a unique case of incidentally noted Trichinella spiralis infection of the head and neck. To our knowledge, this is the first described case of trichinellosis of strap muscle adjacent to an excised TGDC and furthermore highlights the rarity of Trichinella spiralis infections of the head and neck. CONCLUSIONS: Trichinella spiralis may exist subclinically in a variety of human tissues including neck muscles
PMID: 21225756
ISSN: 1531-4995
CID: 121324